@article{Kopel_2019, title={Acquired cystic fibrosis transmembrane conductance regulator protein (CFTR) dysfunction and cigarette smoking}, volume={7}, url={https://pulmonarychronicles.com/index.php/pulmonarychronicles/article/view/562}, DOI={10.12746/swrccc.v7i30.562}, abstractNote={<p><em>Cystic fibrosis (CF) remains a prevalent genetically inherited disease in Caucasian populations. Investigation of the respiratory symptoms which occur in patients with CF helps us understand the pathophysiology of chronic lung disease. Environmental insults, such as cigarette smoke, can reduce the cystic fibrosis transmembrane receptor (CFTR) function or expression leading to an acquired CF phenotype and could contribute to the development and progression of smoking-related lung disease. However, it is uncertain if the acquired CF phenotype can be diagnosed with the same methods, such as the sweat chloride test and the measurement of nasal potential difference, used for genetically-acquired CF. More studies are needed to investigate the prevalence of acquired CFTR dysfunction and the differences between acquired and genetically-inherited CFTR dysfunction. Overall, acquired CFTR dysfunction challenges the distinction between genetic and acquired disorders, suggesting that environmental agents may modulate the functions of genes and the increase risk for pulmonary disease.</em></p> <p><strong><em>Keywords:</em></strong>&nbsp;Cystic fibrosis, acquired cystic fibrosis, smoking, mucociliary clearance</p&gt;}, number={30}, journal={The Southwest Respiratory and Critical Care Chronicles}, author={Kopel, Jonathan}, year={2019}, month={Jul.}, pages={43-46} }